title: Letter by Zito et Al regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham atrial fibrillation treatment of the aged study)".
authors.affiliation: Department of Medicine and Aging, Centre for Aging Sciences, Internal Medicine Unit, University G. D'Annunzio Foundation, Chieti, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Zito
authors.affiliation: Department of Medicine and Aging, Centre for Aging Sciences, Internal Medicine Unit, University G. D'Annunzio Foundation, Chieti, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Lattanzio
authors.affiliation: Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio of Chieti-Pescara, Chieti, Italy.
authors.forename: Marcello
authors.initials: M
authors.lastname: Di Nisio
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D003072:Cognition Disorders / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008297:Male; D014859:Warfarin / Q000494:pharmacology*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin